Skip to main content

Low-Dose Insulin Useful for Puncate Epithelial Corneal Defects



Previous studies have determined that topical insulin use was effective in accelerating epithelial defect closure in patients with neurotrophic keratitis. When epithelialization is not achieved in two weeks with stan­dard initial treatment, this option would is an effective first-­line treatment option.  One study found that topical insulin is a safe and effective alternative to treat epithelial defects that don’t improve despite conventional treatment.

96.8% of eyes achieved closure of the epithelial defect with this treatment.

The average closure time was shorter in non-diabetics compared to diabetics. 9.3% experienced burning and 6.25% reported pain. 


Hernandez AJI, Gomez EA, Velasco R, et al. Effectiveness and safety of topical insulin in persistent epithelial defects refractory to treatment. ARVO 2025 annual meeting.

Comments

Popular posts from this blog

IMPLANTABLE COLLAMER LENS APPEARS BETTER THAN LASIK OR PRK FOR MODERATE TO HIGH MYOPIC PATIENTS

RINSING YOUR CONTACT LENS CASE IS NOT ENOUGH